Burden of disease in COPD, stratified by eosinophils levels: a UK biobank study

生命银行 慢性阻塞性肺病 疾病 医学 肺病 重症监护医学 内科学 生物 生物信息学
作者
Catia C Proenca,Oscar Dumoulin,Aurélie Chekroun Martinot,P Hurtado,Mathieu Rosé
标识
DOI:10.1183/13993003.congress-2023.pa620
摘要

Evidence suggests that blood eosinophil levels (EOS) can influence response to therapy in COPD. This study's objective is to characterize the COPD burden and resource use, stratified by EOS levels. COPD patients were retrieved from the UK biobank, a population-based prospective cohort of 500,000 adults, aged 40-70 recruited between 2006-10 and followed until Dec-2019. Differences in the prevalence of atopic comorbidities at baseline and in yearly mortality rate, all-cause hospitalizations and GP visits during follow-up were assessed. Incidence of severe exacerbations was analyzed by multivariate logistic regressions, and confounders were added by stepwise variable selection. 5,097 COPD patients were followed for 9.9 years (±2.5). The 1,022 (20%) patients with EOS≥300 were older (61.8 vs. 61.3years), had a higher prevalence of males (65 vs 53%), a higher BMI (28.2 vs 27.8), and a higher smoking prevalence (31 vs 27%), than patients EOS<300. Air pollution exposure prevalence was similar. The prevalence of atopic comorbidities (atopic dermatitis, chronic rhinosinusitis with/without polyp, and allergic rhinitis) at baseline was higher in patients with EOS≥300 (10 vs 7%). During the follow-up period, no statistically significant differences were observed in yearly mortality rate, GP visits, and all-cause hospitalizations. EOS≥300 was significantly associated with having 1 or more severe exacerbation during the follow-up period, after controlling for sociodemographic characteristics, smoking status, and atopic comorbidities (adjusted OR=1.20 [95%CI 1.03-1.39], p=0.021). COPD patients with EOS≥300 have more comorbid atopic conditions and experience more frequent severe exacerbations than patients with EOS<300.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
美丽的盼夏完成签到,获得积分20
刚刚
刚刚
王新涛发布了新的文献求助10
刚刚
刚刚
molihuakai的应助被jasmine970000采纳,获得10
刚刚
GSW完成签到,获得积分10
1秒前
汉堡包的应助被山水采纳,获得10
1秒前
简单的草莓完成签到 ,获得积分10
1秒前
1秒前
少吃一口完成签到,获得积分10
1秒前
faker完成签到,获得积分10
1秒前
所所的应助被支摇伽采纳,获得10
2秒前
2秒前
2秒前
无花果的应助被淡淡觅波采纳,获得10
2秒前
田様的应助被月亮采纳,获得10
2秒前
神奇蜥蜴完成签到,获得积分10
2秒前
zzZ5发布了新的文献求助30
3秒前
3秒前
hafa发布了新的文献求助10
3秒前
张淘发布了新的文献求助10
3秒前
我是谁的应助被youtime采纳,获得30
4秒前
4秒前
Owen的应助被Taylor_Zhou采纳,获得10
4秒前
5秒前
迷路的梦凡完成签到,获得积分10
5秒前
薛定谔的猫完成签到,获得积分10
5秒前
八十光年发布了新的文献求助10
5秒前
faye发布了新的文献求助30
5秒前
5秒前
小潘同学完成签到,获得积分10
6秒前
聚乙二醇发布了新的文献求助10
6秒前
kousu完成签到,获得积分10
6秒前
6秒前
林林完成签到,获得积分10
7秒前
懵懂的狗完成签到,获得积分10
7秒前
abb完成签到 ,获得积分10
7秒前
7秒前
wsq完成签到 ,获得积分10
7秒前
FashionBoy的应助被jiaqngyiheng采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287